Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-036970
Filing Date
2026-03-31
Accepted
2026-03-31 09:29:19
Documents
87
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0283072-20f_neurosense.htm   iXBRL 20-F 2424330
2 AMENDED AND RESTATED ARTICLES OF ASSOCIATION ea028307201ex1-1.htm EX-1.1 285028
3 DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF ea028307201ex2-1.htm EX-2.1 55435
4 CERTIFICATION ea028307201ex12-1.htm EX-12.1 9615
5 CERTIFICATION ea028307201ex12-2.htm EX-12.2 9834
6 CERTIFICATION ea028307201ex13-1.htm EX-13.1 3284
7 CERTIFICATION ea028307201ex13-2.htm EX-13.2 3403
8 CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGIS ea028307201ex15-1.htm EX-15.1 2021
9 GRAPHIC ea028307201_img1.jpg GRAPHIC 13557
  Complete submission text file 0001213900-26-036970.txt   8735156

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE nrsn-20251231.xsd EX-101.SCH 58625
11 XBRL CALCULATION FILE nrsn-20251231_cal.xml EX-101.CAL 39671
12 XBRL DEFINITION FILE nrsn-20251231_def.xml EX-101.DEF 292050
13 XBRL LABEL FILE nrsn-20251231_lab.xml EX-101.LAB 535290
14 XBRL PRESENTATION FILE nrsn-20251231_pre.xml EX-101.PRE 301906
91 EXTRACTED XBRL INSTANCE DOCUMENT ea0283072-20f_neurosense_htm.xml XML 968731
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41084 | Film No.: 26817900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)